This service will be located at the Wellcome Genome Campus in Cambridgeshire, providing researchers with streamlined access to various medical research data in one secure location.

Alzheimer’s Society welcomed the initiative, noting that reducing bureaucratic hurdles will facilitate quicker access to vital data for dementia research.

Medical research charities, including Cancer Research UK, have expressed support for the investment, highlighting its potential to unlock NHS data for research and improve disease understanding.

The UK Government and the Wellcome Trust have announced a joint investment of up to £600 million to establish a new health data research service.

John-Arne Rottingen, CEO of Wellcome, emphasized that this initiative will enhance the ability to analyze NHS data, ultimately improving the speed of developing new treatments.

Plans also include standardizing clinical trial contracts to eliminate the need for repeated negotiations, thereby streamlining the trial process.

Sir Keir Starmer has pledged to reduce the time required to set up clinical trials in the UK from over 250 days to 150 days to strengthen the medical sciences industry.

For the first time, clinical trial data will be published at the trust level, enhancing transparency across the NHS.

The initiative aims to accelerate research into critical diseases such as cancer, dementia, and arthritis while ensuring strict patient confidentiality standards are maintained.

Starmer emphasized the importance of Britain's life sciences sector during a visit to Jaguar Land Rover's West Midlands plant, describing it as pivotal to the export economy.